Ensysce Biosciences, Inc. (ENSC)
$0.57+1.79%Close
BUYRECOVERY · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $5M
- Beta
- 1.02
- P/E (TTM)
- -0.21
- Short % float
- 11.66%
- Days to cover
- 3.4
- SI change
- -10.4%
- 1W
- +32.56%
- 1M
- +18.75%
- vs SPY 1W
- +32.70%
- vs SPY 1M
- +16.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on ENSC?
- LOPJLB’s latest quantitative signal on Ensysce Biosciences, Inc. (ENSC) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is ENSC in?
- Ensysce Biosciences, Inc. (ENSC) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Ensysce Biosciences, Inc. (ENSC) do?
- Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical firm dedicated to developing novel prescription drugs for the treatment of severe pain in the United States, with a specific focus on preventing opioid addiction, misuse, abuse, and overdose. The company leverages two primary technological frameworks: the Trypsin Activated Abuse Protection (TAAP) platform, which creates opioid prodrug…